Hofseth Biocare ASA: Proxy Rights at Extraordinary General Meeting
20 September 2016 - 11:01AM
Roger Hofseth, Chairman of
the Board of Hofseth BioCare ASA, has in connection to the upcoming
Extraordinary General Meeting today 20 September 2016, received
proxy rights from shareholders representing 66 670 905 shares in
the company, equal to 54.55 per cent of the voting rights.
Roger Hofseth owns as per
the registration date for the EGM a total of 24 831 109 shares,
equal to 20.32 per cent of the outstanding shares in the company.
20 981 109 shares are owned via his fully owned company, Roger
Hofseth AS, and 3 850 000 shares via a forward contract.
After the receipt of the
above-mentioned proxies, Mr. Hofseth represents a total of 91 502
014 shares, equal to 74.87 per cent of the voting rights at the
Extraordinary General meeting in Hofseth BioCare ASA.
Also, reference is made to
the notification of 30 August 2016 for convening the EGM in Hofseth
BioCare ASA on 20 September 2016. Attached report on share capital
increase (in Norwegian), dated 20 September 2016 for the conversion
of debt to equity, issued by EY.
For further information,
please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.
EY report on share capital
increase
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Hofseth Biocare ASA via Globenewswire